Shares of Clorox Co (NYSE:CLX) are trading higher on Tuesday after the company reported better-than-expected first-quarter financial results. Clorox also affirmed its FY27 adjusted EPS guidance above estimates.

Clorox Beats Q1 Expectations

Clorox reported first-quarter adjusted EPS of $1.55, up 82% from a year earlier and above the $1.07 analyst estimate. Total revenue rose 33% to $1.91 billion, topping the $1.88 billion estimate. The company noted that organic sales were up 18%.

Gross margin fell 130 basis points to 40.4%, mainly due to higher commodity, manufacturing and logistics costs. The company now expects fiscal 2027 input cost inflation of $240 million, up $40 million from its prior expectation.

Clorox affirmed fiscal 2027 adjusted EPS guidance of $5.70 to $6.00, versus the $5.70 estimate. It also affirmed GAAP EPS guidance of $5.41 to $5.71, versus the $5.70 estimate, and sales guidance of $7.594 billion to $7.661 billion, versus the $7.631 billion estimate.

Analysts Adjust Price Targets

Multiple analysts raised price targets on Clorox stock following the company’s quarterly results.

  • UBS maintained a Neutral rating on Clorox and raised its price target to $96.
  • Wells Fargo maintained an Equal-Weight rating and raised its price target to $90.
  • JPMorgan maintained an Underweight rating and raised the price target to $86.

Clorox has a consensus Neutral rating among analysts with an average price target of $106, according to Benzinga data.

CLX Shares Move Higher

CLX Price Action: Clorox shares were up 2.22% at $91.90 at the time of publication on Tuesday, according to Benzinga Pro.

Image: Shutterstock.com